Japan
MedHub-AI Secures PMDA Approval in Japan for AutocathFFR®, the World’s First Fully Automated AI-Driven FFR Solution
MedHub-AI, a global leader in AI-powered cardiovascular diagnostics, announced today that the Pharmaceuticals and Medical Devices Agency (PMDA) in&nb...
June 19, 2025 | News
NEC and Chugai Harness AI to Halve Time Needed for Predicting Effective Cancer Drug Combinations
Identified the potential to reduce the time required to research and predict drug combinations by approximately 50% NEC Corporation (NEC; TSE: ...
June 19, 2025 | News
Hoth Therapeutics Secures Japan Patent for HT-KIT Splice-Switching Platform Targeting Mast Cell Disorders
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained...
June 13, 2025 | News
Samsung Bioepis Partners with NIPRO to Expand Biosimilar Access in Japan
Samsung Bioepis expands its presence in Japanese market through partnership with NIPRO Corporation Marks a step forward in widening treatments options a...
June 09, 2025 | News
FUJIFILM Unifies Life Sciences Brands to Deliver End-to-End Drug Development Solutions
FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a c...
June 04, 2025 | News
Singapore Approves Astellas’ VEOZA™ (Fezolinetant) for Moderate to Severe Menopausal Vasomotor Symptoms
Astellas Singapore has announced that the Health Sciences Authority (HSA) of Singapore has approved VEOZA™ (fezolinetant) 45 mg for the treatment of ...
June 04, 2025 | News
Eisai’s DAYVIGO® Approved in China to Treat Insomnia, Targeting Over 170 Million Adults
Eisai Co., Ltd. announced that the in-house-discovered and developed orexin receptor antagonist DAYVIGO® (generic name: lemborexant) has been app...
May 29, 2025 | News
Fujifilm Validates Cancer-Targeting Potential of Peptide-Oligonucleotide Conjugates Using Proprietary Cyclic Peptide Library
FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of its peptide-oligonucleotide conjugates. This validation ...
May 21, 2025 | News
RevolKa Secures $1.4M in Series A Extension to Advance AI-Driven Rare Disease Drug Discovery
RevolKa Ltd. (RevolKa), a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform called aiProtein&r...
May 21, 2025 | News
AstraZeneca and Daiichi Sankyo’s ENHERTU Demonstrates Superior pCR in Early HER2+ Breast Cancer in Phase 3 DESTINY-Breast11 Trial
Positive topline results from the DESTINY-Breast11 phase 3 trial showed ENHERTU® (trastuzumab deruxtecan) followed by paclitaxel, trastu...
May 08, 2025 | News
Ajinomoto and RIBOMIC Advance Next-Gen Aptamer Therapeutics with Extended Half-Life Using AJICAP® Technology
Ajinomoto Co., Inc. has been conducting joint research* with RIBOMIC Inc. (President: Yoshikazu Nakamura, Headquarters: Minato-ku, Tokyo, hereinafter refer...
May 07, 2025 | News
AGC Biologics Partners with South Korea’s Novelty Nobility to Advance Bispecific Antibody Program Across Europe and Asia
Global CDMO supports South Korean company on a multiphase project at its Copenhagen and Chiba sites AGC Biologics, your friendly CDMO expert, an...
May 06, 2025 | News
Henlius Licenses Ipilimumab Biosimilar HLX13 to Sandoz in $301M Global Deal
Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $...
April 30, 2025 | News
GHIT Fund Commits USD 4.6 Million to Tackle TB and Neglected Diseases in Low- and Middle-Income Regions
The Global Health Innovative Technology (GHIT) Fund announced an investment of approximately JPY 679 million (USD 4.5 million) for the...
April 23, 2025 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
